Literature DB >> 16253240

Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.

Young Ho Kim1, Ki Sa Sung, Sook-Jeong Lee, Yong-Ou Kim, Cheol Yong Choi, Yongsok Kim.   

Abstract

The modification of homeodomain-interacting protein kinase 2 (HIPK2) by small ubiquitin-like modifier 1 (SUMO-1) plays an important role in its targeting into the promyelocytic leukemia body, as well as in its differential interaction with binding partner, but the desumoylation of HIPK2 by SUMO-specific proteases is largely unknown. In this study, we show that HIPK2 is a desumoylation target for the SUMO-specific protease SENP1 that shuttles between the cytoplasm and the nucleus. Mutation analyses reveal that SENP1 contains the nuclear export sequence (NES) within the extreme carboxyl-terminal region, and SENP1 is exported to the cytoplasm in a NES-dependent manner. Sumoylated HIPK2 are deconjugated by SENP1 both in vitro and in cultured cells, and the desumoylation is enhanced either by the forced translocation of SENP1 into the nucleus or by the SENP1 NES mutant. Concomitantly, desumoylation induces dissociation of HIPK2 from nuclear bodies. These results demonstrate that HIPK2 is a target for SENP1 desumoylation, and suggest that the desumoylation of HIPK2 may be regulated by the cytoplasmic-nuclear shuttling of SENP1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253240     DOI: 10.1016/j.febslet.2005.10.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease.

Authors:  Zheng Xu; So Fun Chau; Kwok Ho Lam; Ho Yin Chan; Tzi Bun Ng; Shannon W N Au
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 2.  SUMOylation and De-SUMOylation: wrestling with life's processes.

Authors:  Edward T H Yeh
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 3.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

4.  HIPK2 is necessary for type I interferon-mediated antiviral immunity.

Authors:  Lili Cao; Guang Yang; Shandian Gao; Chunxia Jing; Ruth R Montgomery; Yuxin Yin; Penghua Wang; Erol Fikrig; Fuping You
Journal:  Sci Signal       Date:  2019-03-19       Impact factor: 8.192

Review 5.  Emerging roles of SUMO modification in arthritis.

Authors:  Dongyao Yan; Francesca J Davis; Andrew D Sharrocks; Hee-Jeong Im
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

6.  Distribution and paralogue specificity of mammalian deSUMOylating enzymes.

Authors:  Nagamalleswari Kolli; Jowita Mikolajczyk; Marcin Drag; Debaditya Mukhopadhyay; Nela Moffatt; Mary Dasso; Guy Salvesen; Keith D Wilkinson
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

7.  Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.

Authors:  Isha Sengupta; Dipanwita Das; Shivaram Prasad Singh; Runu Chakravarty; Chandrima Das
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

Review 8.  SUMO--a post-translational modification with therapeutic potential?

Authors:  Chang-Hoon Woo; Jun-Ichi Abe
Journal:  Curr Opin Pharmacol       Date:  2010-01-14       Impact factor: 5.547

9.  Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.

Authors:  Prashant Sharma; Satoru Yamada; Margaret Lualdi; Mary Dasso; Michael R Kuehn
Journal:  Cell Rep       Date:  2013-05-16       Impact factor: 9.423

10.  Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.

Authors:  Kristin E Yates; Gregory A Korbel; Michael Shtutman; Igor B Roninson; Daniel DiMaio
Journal:  Aging Cell       Date:  2008-07-24       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.